Skip to content
Review Open access

From RNA fate to cancer state transitions: m5C-driven metabolic and immune reprogramming (Review)

Oct 2026 · International Journal of Molecular Medicine · Vol 58 · 0 citations · 139 references
Medicine

TL;DR

Clinical translation requires relating treatment-induced RNA changes to drug exposure, tumor selectivity and immune-cell function, rather than relying on regulator expression alone.

Abstract

RNA 5-methylcytosine (m5C) regulates RNA stability, processing and translation, linking changes in nutrient supply and stress to cancer-cell behavior. Its consequences depend on the RNA substrate and the proteins that recognize or process the modification. This dependence helps explain why NOP2/Sun RNA methyltransferase 2 (NSUN2), NOP2 nucleolar protein, NSUN5, NSUN6 and tRNA aspartic acid methyltransferase 1 can affect proliferation, metabolism, immunity and treatment response differently. Across coding and noncoding RNAs, m5C regulation can sustain growth-related protein expression, alter DNA damage repair and support metabolic defenses against cell death. Metabolites also regulate writers and readers, creating feedback in specific tumor models that connects nutrient availability with RNA recognition. These relationships suggest several therapeutic approaches, including nucleoside analogues, writer or reader inhibition, substrate-RNA targeting and tumor-directed delivery. Experimental combinations can restore drug sensitivity, although simultaneous effects on immune cells or normal tissues may limit systemic treatment. Clinical translation requires relating treatment-induced RNA changes to drug exposure, tumor selectivity and immune-cell function, rather than relying on regulator expression alone.

Read PDF

Similar papers

Review Open access Oct 2026

Compartment-specific m7G RNA modification in cancer: mechanisms, tumor adaptation, and therapeutic vulnerabilities

N7-methylguanosine (m 7 G) is distributed across several RNA classes and regulates distinct stages of gene expression. The best-characterized form is the 5′cap of messenger RNA, although m 7 G also occurs in transfer RNA, ribosomal RNA, internal messenger RNA, circular RNA, and transfer RNA-derived small RNAs. Ca...

Xiao-Xiao Tian, Di Huang, Chao Guan · 0 citations
Review Sep 2026

RNA modifications and metabolism in cancer: mechanisms, cross-talk and therapeutic implications.

This review synthesizes current knowledge on how RNA modifications coordinate glucose, lipid, glutamine and nucleotide metabolism, with emphasis on cross-talk and functional integration among different marks to discuss tumor-type-specific wiring of these networks.

Xin Luo, Xin-Zhao Zuo, Jing-Ke He et al. · 0 citations
Review Open access Oct 2026

RNA N4-acetylcytidine modification in health and cancer: molecular mechanisms, cellular plasticity, and therapeutic opportunities

N⁴-acetylcytidine (ac⁴C) is an evolutionarily conserved RNA modification that was initially identified in transfer RNA (tRNA) and ribosomal RNA (rRNA). Increasing evidence has subsequently expanded its functional landscape to messenger RNA (mRNA) and multiple classes of non-coding RNAs (ncRNAs). As the best-characteriz...

Xiao-Yan He, Kang Du, Chao-Fu Yue et al. · 0 citations
Review Open access Sep 2026

The role and clinical impact of aberrant m6A RNA modification in cancer

This review systematically dissects how dysregulated m6A methylation fuels malignant transformation and progression by reinforcing core oncogenic hallmarks, sustained proliferation, metastasis, metabolic rewiring, and resistance to programmed cell death.

Sheng-Jie Tang, Rangping Xie, Jiang Fu et al. · 0 citations
Review Open access Sep 2026

The Crosstalk Between Metabolic Reprogramming and Histone Methylation in Tumor Immunity and Immunotherapy

Histone methylation regulates chromatin structure and gene expression, whereas tumor metabolism provides bioenergetic and biosynthetic inputs. These processes are bidirectionally linked: S-adenosylmethionine supplies methyl groups for histone methyltransferases, α-ketoglutarate(α-KG) supports JmjC-domain demethylases,...

Jia-Yao Dou, Rui-Cheng Xue, Wei Gao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.